These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 396228

  • 21. [Prerequisites for enhancement of the efficacy of fosfomycin by glucose-6-phosphate in treatment of experimentally infected animals (author's transl)].
    Hirschl A, Stanek G, Rotter M, Holzmann A, Frisch-Niggemeyer W, Laber G.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):529-39. PubMed ID: 7036592
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.
    Burian A, Erdogan Z, Jandrisits C, Zeitlinger M.
    Pharmacology; 2012 Nov; 90(5-6):281-7. PubMed ID: 23037005
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An improved susceptibility test based on Amberlite reveals the potential antilisterial activity of fosfomycin in vitro.
    Han L, Lei J, Han S, He L, Ma C, Yu P, Wu X, Xu J.
    Can J Microbiol; 2013 Apr; 59(4):252-9. PubMed ID: 23586749
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Antibacterial activity of fosfomycin. II. Determination of minimal bactericidal concentration in association with other antibiotics].
    Grassi GG, Ferrara A, Navone A, Peona V, Sala P.
    G Ital Chemioter; 1977 Apr; 23(2):87-94. PubMed ID: 606614
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. ["In vitro" determination of bacterial sensitivity to tobramycin (author's transl)].
    Talon D, Michel-Briand Y.
    Pathol Biol (Paris); 1976 Jan; 24(1):25-30. PubMed ID: 817253
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
    Russo G, Toscano MA, Gismondo MR, Nicolosi V, Garaci E.
    Ann Sclavo; 1980 Jan; 22(1):77-82. PubMed ID: 7247487
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Comparison between the in-vitro antibacterial activity of fosfomycin as determined using the M.I.C. and using the antibiogram].
    Renzini G, Oliva B.
    G Ital Chemioter; 1977 Jan; 23(2):117-22. PubMed ID: 606610
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.